Fig. 3From: Is switching intravesical chemotherapeutic agents beneficial in short-term recurrent high-risk non-muscle-invasive bladder tumors? A 5-year retrospective studyKaplan–Meier curves of 5-year progression-free survival are shown. There was no statistically significant difference between the two groups' Kaplan–Meier curves for progression-free survivalBack to article page